Antibody capable of binding to thymic stromal lymphopoietin and use therof
US-2026022166-A1 · Jan 22, 2026 · US
Wang Yifang is listed as an inventor on 17 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Wang Yifang |
| Total patents | 17 |
| First publication | Apr 12, 2018 |
| Latest publication | Jan 22, 2026 |
Publications ranked by popularity score, then publication date.
US-2026022166-A1 · Jan 22, 2026 · US
US-2025333494-A1 · Oct 30, 2025 · US
US-12404323-B2 · Sep 2, 2025 · US
US-12321580-B2 · Jun 3, 2025 · US
US-12258394-B2 · Mar 25, 2025 · US
US-2025034690-A1 · Jan 30, 2025 · US
US-12209301-B1 · Jan 28, 2025 · US
US-12202891-B2 · Jan 21, 2025 · US
US-2024254215-A1 · Aug 1, 2024 · US
US-2024208144-A1 · Jun 27, 2024 · US
Latest publications not already listed above.
US-2023152956-A1 · May 18, 2023 · US
US-2022356239-A1 · Nov 10, 2022 · US
US-2022340654-A1 · Oct 27, 2022 · US
US-11365247-B2 · Jun 21, 2022 · US
US-2020369774-A1 · Nov 26, 2020 · US
US-10449250-B2 · Oct 22, 2019 · US
US-2018099046-A1 · Apr 12, 2018 · US
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Jiangsu Hengrui Medicine Co | 12 |
| Shanghai hengrui pharmaceutical co ltd | 12 |
| Vivo Mobile Communication Co Ltd | 2 |
| Univ Inner Mongolia Technology | 2 |
| Univ Jiliang China | 2 |
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| C07K2317/76 | 12 |
| C07K2317/92 | 12 |
| C07K2317/24 | 12 |
| A61K2039/505 | 12 |
| C07K2317/565 | 10 |